What is the recommended surveillance and management strategy for an aortic mural thrombus?

Surveillance for Aortic Mural Thrombus

For primary aortic mural thrombus (PAMT), perform baseline CT angiography (CTA) immediately, initiate anticoagulation, and obtain repeat imaging at 1-3 months to assess thrombus resolution or persistence, with subsequent surveillance intervals determined by thrombus behavior and treatment response.

Initial Imaging Assessment

When PAMT is suspected or identified:

• Use ECG-gated contrast-enhanced CTA as the gold standard for diagnosis and characterization 1. Non-gated CT is prone to motion artifacts that can miss or mischaracterize thrombi, particularly in the ascending aorta.
• Assess the entire aorta at baseline when any aortic thrombus is identified 2. This is critical because thrombus location predicts embolization patterns—infrarenal thrombi typically embolize to lower extremities, while suprarenal and thoracic thrombi more commonly cause visceral or cerebral embolization 3.
• Transesophageal echocardiography (TEE) has significant blind spots in the distal ascending aorta and should not be relied upon alone 4.

Surveillance Intervals

The evidence base for PAMT surveillance is limited, as major guidelines focus on aneurysmal disease rather than mural thrombus. However, based on available research:

Early surveillance (first 3-6 months):

• Obtain repeat CTA at 1-3 months after diagnosis to assess treatment response 5, 6
• In the largest recent series, thrombus regression or resolution occurred in 78% of patients during early follow-up (median 3 months), while persistent thrombus occurred in 22% 3
• Close monitoring is essential because recurrent embolization occurred in 13-25% of patients in recent series 3, 5

Subsequent surveillance:

• If thrombus resolves: Consider repeat imaging at 6 months, then annually for 1-2 years
• If thrombus persists despite anticoagulation: Repeat imaging every 3 months and strongly consider endovascular or surgical intervention
• If thrombus recurs: Immediate re-imaging and escalation to interventional therapy

Critical Management Considerations

Anticoagulation alone carries substantial risks:

• Thrombus persistence in 26-35% of cases 6, 7
• Recurrent embolization in 25-50% 6, 7
• Need for secondary aortic surgery in up to 31% 6

High-risk features requiring more aggressive surveillance and consideration for intervention:

• Mobile or pedunculated thrombus morphology 7
• Thrombus in ascending aorta or arch (12-18 times higher recurrence risk) 7
• Mild atherosclerosis of aortic wall (2.5 times higher recurrence risk) 7
• Presentation with stroke (12 times higher recurrence risk) 7
• Persistent thrombus despite 3 months of anticoagulation

Imaging Modality Selection

• CTA is preferred for PAMT surveillance due to superior visualization of thrombus morphology, mobility, and relationship to branch vessels 2
• CMR is reasonable if radiation exposure is a concern, though spatial resolution may be inferior for small thrombi 2
• Duplex ultrasound is inadequate for thoracic aortic thrombus surveillance 2

Common Pitfalls

• Do not rely on non-gated CT—motion artifacts can simulate or obscure thrombus 1
• Do not assume resolution without imaging confirmation—clinical improvement does not guarantee thrombus resolution
• Do not delay intervention in high-risk patients—waiting for recurrent embolization increases morbidity and mortality (90-day mortality 8.7% even with treatment) 3
• Screen for prothrombotic disorders—present in 92% of PAMT cases and influences long-term anticoagulation strategy 5

The lack of formal guidelines reflects the rarity of this condition, but emerging evidence suggests that endovascular coverage (when anatomically feasible) may be superior to anticoagulation alone, with lower recurrence rates 6, 8. Surveillance strategy should be more intensive than for stable aneurysmal disease given the high early embolization risk.